FGL1 and metabolic dysfunction-associated steatotic liver disease: Hepatic expression of FGL-1 increases in the high-fat diet–fed mice with NAFLD, in turn led to activation of ERK1/2 in order to facilitate lipogenesis, ultimately is associated with development of hepatic steatosis (26).